Loading the company…
Loading the company…
Families: SI joint fusion, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 16 decisions for SI-BONE (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2022 (4). The latest was on 2026-09-23.
| Family | Decisions on record |
|---|---|
| SI joint fusion | 27 |
| Lumbar fusion | 1 |
In 2025, SI-BONE reported engagement with 537 surgeons and other clinicians in the states MedaRep covers, worth $2.5M in consulting, speaking, meals and travel for its device products, the most in Washington ($228K to 25). Royalties are left out.
| iFuse TORQ® Implant System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to SI-BONE.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Washington ($228K, 25 engaged), Florida ($216K, 53 engaged), California ($206K, 53 engaged), Pennsylvania ($181K, 17 engaged), Minnesota ($177K, 25 engaged).